Conavi Medical Corp. (TSXV:CNVI)
0.420
-0.010 (-2.33%)
Mar 9, 2026, 9:30 AM EST
Conavi Medical Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| Cash & Equivalents | 0.97 | 5.84 | 0.44 | 14.17 | 4.59 |
| Cash & Short-Term Investments | 0.97 | 5.84 | 0.44 | 14.17 | 4.59 |
| Cash Growth | 122.71% | 1239.68% | -96.92% | 208.96% | - |
| Accounts Receivable | 0.38 | 0.41 | 0.67 | 0.73 | 0.23 |
| Other Receivables | 0.33 | 0.27 | 0.27 | 0.29 | 0.47 |
| Receivables | 0.71 | 0.67 | 0.94 | 1.02 | 0.69 |
| Inventory | 0.07 | 0.34 | 1.61 | 2.8 | 2.76 |
| Prepaid Expenses | 3.06 | 1.42 | 0.55 | 1.18 | 0.55 |
| Total Current Assets | 5.77 | 8.27 | 3.53 | 19.16 | 8.59 |
| Property, Plant & Equipment | 1.86 | 2.02 | 2.74 | 3.37 | 3.91 |
| Other Intangible Assets | 2.21 | 2.16 | 2.3 | 2.29 | 2.44 |
| Total Assets | 9.84 | 12.44 | 8.56 | 24.82 | 14.94 |
| Accounts Payable | 4.95 | 2.91 | 6 | 3.55 | 1.63 |
| Short-Term Debt | 0.96 | - | 21.29 | - | - |
| Current Portion of Long-Term Debt | 1.13 | 1.11 | 0.51 | 1.05 | 1 |
| Current Portion of Leases | 0.6 | 0.8 | 0.26 | 0.23 | 0.19 |
| Current Unearned Revenue | 0.52 | 0.61 | 0.14 | 0.36 | 0.02 |
| Other Current Liabilities | 1.42 | 2.79 | - | - | - |
| Total Current Liabilities | 9.58 | 8.21 | 28.19 | 5.18 | 2.84 |
| Long-Term Debt | 16.28 | 17.27 | 60.11 | 51.87 | 29.19 |
| Long-Term Leases | 0.6 | 0.73 | 1 | 1.26 | 1.49 |
| Long-Term Unearned Revenue | 4.13 | 4.26 | 5.09 | 5.22 | 5.38 |
| Total Liabilities | 30.59 | 30.47 | 94.39 | 63.53 | 38.9 |
| Common Stock | 126.79 | 126.79 | 17.55 | 17.54 | 17.54 |
| Additional Paid-In Capital | 16.47 | 16.23 | 20.69 | 24.23 | 12.41 |
| Retained Earnings | -169.71 | -167 | -146.49 | -102.87 | -76.78 |
| Comprehensive Income & Other | 5.7 | 5.95 | 4 | 3.98 | 3.25 |
| Total Common Equity | -20.75 | -18.03 | -104.24 | -57.12 | -43.58 |
| Shareholders' Equity | -20.75 | -18.03 | -85.83 | -38.71 | -23.96 |
| Total Liabilities & Equity | 9.84 | 12.44 | 8.56 | 24.82 | 14.94 |
| Total Debt | 19.57 | 19.91 | 83.18 | 54.41 | 31.88 |
| Net Cash (Debt) | -18.6 | -14.07 | -82.74 | -40.24 | -27.29 |
| Net Cash Per Share | -0.29 | -0.24 | -13.43 | -6.54 | -4.43 |
| Filing Date Shares Outstanding | 67.63 | 76.75 | 44.25 | 6.16 | 6.16 |
| Total Common Shares Outstanding | 67.63 | 76.75 | 6.16 | 6.16 | 6.16 |
| Working Capital | -3.8 | 0.06 | -24.67 | 13.98 | 5.75 |
| Book Value Per Share | -0.31 | -0.23 | -16.92 | -9.28 | -7.08 |
| Tangible Book Value | -22.97 | -20.18 | -106.54 | -59.41 | -46.02 |
| Tangible Book Value Per Share | -0.34 | -0.26 | -17.29 | -9.65 | -7.48 |
| Machinery | 3.82 | 3.79 | 4.25 | 4.34 | 4.47 |
| Leasehold Improvements | 1.15 | 1.15 | 1.15 | 1.12 | 1.09 |
Source: S&P Capital IQ. Standard template. Financial Sources.